MX2009010850A - Sintesis de ibandronato en multiples etapas. - Google Patents

Sintesis de ibandronato en multiples etapas.

Info

Publication number
MX2009010850A
MX2009010850A MX2009010850A MX2009010850A MX2009010850A MX 2009010850 A MX2009010850 A MX 2009010850A MX 2009010850 A MX2009010850 A MX 2009010850A MX 2009010850 A MX2009010850 A MX 2009010850A MX 2009010850 A MX2009010850 A MX 2009010850A
Authority
MX
Mexico
Prior art keywords
step synthesis
ibandronate
multi step
hydroxypropane
monohydrate
Prior art date
Application number
MX2009010850A
Other languages
English (en)
Inventor
Bernd Junghans
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009010850A publication Critical patent/MX2009010850A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se relaciona con una síntesis de pasos múltiples novedosa de ácido de 3-(N-metil-N-pentil) amino-1- hidroxipropano-1,1-difosfónico, sal monosódica, monohidrato, de la Fórmula (I).
MX2009010850A 2007-04-11 2008-04-01 Sintesis de ibandronato en multiples etapas. MX2009010850A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105915 2007-04-11
PCT/EP2008/053876 WO2008125483A2 (en) 2007-04-11 2008-04-01 Multi step synthesis of ibandronate

Publications (1)

Publication Number Publication Date
MX2009010850A true MX2009010850A (es) 2009-11-02

Family

ID=39722497

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010850A MX2009010850A (es) 2007-04-11 2008-04-01 Sintesis de ibandronato en multiples etapas.

Country Status (16)

Country Link
US (1) US7662990B2 (es)
EP (1) EP2144919B1 (es)
JP (1) JP5220843B2 (es)
KR (1) KR101150662B1 (es)
CN (1) CN101679465B (es)
AU (1) AU2008238058B2 (es)
BR (1) BRPI0809548A8 (es)
CA (1) CA2683971C (es)
DK (1) DK2144919T3 (es)
ES (1) ES2558383T3 (es)
HU (1) HUE026660T2 (es)
IL (1) IL201307A (es)
MX (1) MX2009010850A (es)
PL (1) PL2144919T3 (es)
SI (1) SI2144919T1 (es)
WO (1) WO2008125483A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100125149A1 (en) * 2007-04-19 2010-05-20 Dr. Reddy's Laboratories Ltd. Ibandronate sodium polymorphs
WO2011016738A1 (en) * 2009-08-05 2011-02-10 Zaklady Farmaceutyczne Polpharma Sa A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate
CN101863919B (zh) * 2010-07-05 2011-11-23 武汉同源药业有限公司 一种化合物伊班膦酸钠的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919321A (en) 1966-11-08 1975-11-11 Hoffmann La Roche Halo-substituted-5H-dibenzo{8 a,d{9 cyclohepten-5-ones
DE2534391C2 (de) 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
US4220611A (en) 1978-06-29 1980-09-02 Sandoz, Inc. Polyoxyalkylene bridged phosphate esters
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3808074A1 (de) 1988-03-11 1989-09-21 Henkel Kgaa Verfahren zur herstellung von azacycloalkan-2,2-diphosphonsaeuren
DE3822650A1 (de) 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4922007A (en) 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
PL373574A1 (en) * 2002-05-17 2005-09-05 Teva Pharmaceutical Industries Ltd. Use of certain diluents for making bisphosphonic acids
DK1656386T3 (da) * 2003-08-21 2010-04-19 Sun Pharmaceuticals Ind Ltd Fremgangsmåde til fremstilling af bisphosphonsyreforbindelser
ATE508134T1 (de) 2003-12-23 2011-05-15 Alchymars S P A Amorphe form das natriumsalzes der ibandronsäure
MX2007000087A (es) * 2004-06-23 2007-11-06 Teva Pharma Acido ibandronico solido y cristalino.
ES2358269T3 (es) 2004-08-23 2011-05-09 Teva Pharmaceutical Industries Ltd Forma cristalina del ibandronato sódico y procedimientos para su preparación.
US7214818B2 (en) 2004-10-29 2007-05-08 Hoffmann-La Roche Inc. Method for synthesizing bisphosphonate
EP1848727B1 (en) 2005-02-01 2015-06-17 F.Hoffmann-La Roche Ag Ibandronate polymorph b
EP2662380B1 (en) 2005-02-01 2018-11-21 Atnahs Pharma UK Limited Medical use of Ibandronate polymorph A
WO2007013097A1 (en) * 2005-07-25 2007-02-01 Natco Pharma Limited Improved process for the preparation of ibandronate sodium

Also Published As

Publication number Publication date
JP5220843B2 (ja) 2013-06-26
EP2144919B1 (en) 2015-12-02
IL201307A (en) 2013-10-31
IL201307A0 (en) 2010-05-31
DK2144919T3 (en) 2015-12-14
WO2008125483A3 (en) 2008-12-18
KR101150662B1 (ko) 2012-05-29
AU2008238058B2 (en) 2010-12-02
ES2558383T3 (es) 2016-02-03
PL2144919T3 (pl) 2016-05-31
KR20090130117A (ko) 2009-12-17
HUE026660T2 (en) 2016-07-28
EP2144919A2 (en) 2010-01-20
CA2683971C (en) 2013-02-26
CA2683971A1 (en) 2008-10-23
CN101679465B (zh) 2013-08-21
BRPI0809548A8 (pt) 2018-10-16
SI2144919T1 (sl) 2016-02-29
US20080255386A1 (en) 2008-10-16
JP2010523614A (ja) 2010-07-15
US7662990B2 (en) 2010-02-16
WO2008125483A2 (en) 2008-10-23
AU2008238058A1 (en) 2008-10-23
CN101679465A (zh) 2010-03-24
BRPI0809548A2 (pt) 2014-09-16

Similar Documents

Publication Publication Date Title
MX2007005114A (es) Proceso para la preparacion de ibandronato.
TW200640940A (en) Ibandronate polymorph B
TW200638939A (en) Ibandronate polymorph A
TW200801027A (en) Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
IN2012DN02751A (es)
MX2012003343A (es) Proceso para preparar compuestos azabiciclicos.
CR9369A (es) Compuestos de peridil acido acetico
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
UA102817C2 (ru) Способ синтеза агомелатина
MA32977B1 (fr) Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol
MX344153B (es) Proceso para la preparación de sales de pirrolidinio.
UA106619C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
UA101835C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
UA102220C2 (ru) Способ синтеза агомелатина
EP2666765A3 (en) Process for the preparation of substituted 3-(1-amino-2-methyl-pentane-3-yl)phenyl compounds
MX2011006095A (es) Dihidroetorfina y su preparacion.
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
EA201170721A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов рецептора хемокина
UA106195C2 (ru) Способ синтеза агомелатина
MX2009010850A (es) Sintesis de ibandronato en multiples etapas.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
IN2014MN00971A (es)
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.

Legal Events

Date Code Title Description
FG Grant or registration